ABIVAX (EPA:ABVX) | WebDisclosure

Basculer en Français

9480	Companies
185564	Keywords
117973	Articles
99402	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 09/25/2024 at 22:01, 1 year 2 months ago

Abivax Provides Update on Ulcerative Colitis Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease Mouse Model
Abivax announces preclinical data of Obefazimod and Etrasimod combination therapy in IBD mouse model, aiming to break through efficacy ceiling in UC treatment. More updates expected in Q4 2024

Abivax Obefazimod Preclinical Data Etrasimod IBD Mouse Model
PRESS RELEASE

published on 09/25/2024 at 22:01, 1 year 2 months ago

Abivax fait le point sur la stratégie du programme de traitement combiné dans la RCH et annonce les données précliniques précoces de combinaison d’obefazimod et d’étrasimod dans un modèle murin MICI
Abivax annonce des données précliniques de combinaison d'obefazimod et d'étrasimod dans un modèle murin MICI pour traiter la RCH. Prochaine publication au T4 2024

Abivax Obefazimod Etrasimod Traitement Combiné RCH
BRIEF

published on 09/19/2024 at 18:05, 1 year 2 months ago

ABIVAX : Nombre d’actions et droits de vote au 31 août 2024

Euronext Paris Droits De Vote Capital Social Biotechnologie Abivax
BRIEF

published on 09/19/2024 at 18:05, 1 year 2 months ago

ABIVAX: Number of shares and voting rights as of August 31, 2024

Euronext Paris Share Capital Voting Rights Biotechnology Abivax
PRESS RELEASE

published on 09/19/2024 at 18:00, 1 year 2 months ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.24.
ABIVAX communique sur le nombre d'actions et de droits de vote au 31.08.24, conformément aux dispositions réglementaires. Société biotechnologique spécialisée en traitements thérapeutiques innovants

Droits De Vote Capital Social Biotechnologie Abivax Traitements Thérapeutiques
BRIEF

published on 09/09/2024 at 23:01, 1 year 2 months ago

Déclaration de Marc de Garidel sur le Rapport Financier Semestriel 2024 d'Abivax

Abivax Transparence IFRS Rapport Financier Patrimoine
BRIEF

published on 09/09/2024 at 23:01, 1 year 2 months ago

Statement by Marc de Garidel on Abivax's 2024 Half-Year Financial Report

Financial Report Abivax Transparency IFRS Heritage
PRESS RELEASE

published on 09/09/2024 at 22:56, 1 year 2 months ago

Attestation du responsable du Rapport financier semestriel 2024
Déclaration de la personne responsable du rapport financier intermédiaire pour le semestre écoulé conforme aux normes IFRS, présentant une image fidèle de la société

Déclaration Rapport Financier Normes IFRS Semestre Personne Responsable
PRESS RELEASE

published on 09/09/2024 at 22:53, 1 year 2 months ago

Rapport des CAC sur l'information financière semestrielle 2024
PRESS RELEASE

published on 09/09/2024 at 22:43, 1 year 2 months ago

Rapport CAC sur l'information financière semestrielle 2024

Accesswire

Published on 12/06/2025 at 02:00, 14 hours 7 minutes ago

Northern Dynasty Provides Update on Board Search and Audit & Risk Committee Composition
Published on 12/06/2025 at 01:15, 14 hours 52 minutes ago

Prospect Ridge Announces Closing of Flow-Through Unit Private Placement
Published on 12/06/2025 at 00:25, 15 hours 42 minutes ago

GMV Minerals Announces Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Published on 12/06/2025 at 00:00, 16 hours 7 minutes ago

Bird River Announces Closing of $0.10 Common Share Financing
Published on 12/05/2025 at 23:30, 16 hours 37 minutes ago

55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 22:15, 17 hours 52 minutes ago

CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 17 hours 55 minutes ago

EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 21 hours 9 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 21 hours 41 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 21 hours 52 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd

Les Echos

Published on 12/06/2025 at 13:26, 2 hours 41 minutes ago

Total number of voting rights and shares making up the share capital at November30, 2025
Published on 12/06/2025 at 13:26, 2 hours 41 minutes ago

Capital et droits de vote au 30 novembre 2025
Published on 12/05/2025 at 23:00, 17 hours 7 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 17 hours 7 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 17 hours 7 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025

View all LES ECHOS COMFI WIRE